Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2015

1
Glycogen Storage Disorders (GSD) Global Clinical
Trials Review, H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• The report offers coverage of disease clinical
  trials by region, country (G7 E7) , phase,
  trial status, end points status and sponsor type.
  Report also provides prominent drugs for
  in-progress trials (based on number of ongoing
  trials) . Global Data Clinical Trial Reports are
  generated using Global Datas proprietary database
  Pharma eTrack Clinical trials database. Clinical
  trials are collated from 80 different clinical
  trial registries, conferences, journals, news etc
  across the globe. Clinical trials database
  undergoes periodic update by dynamic process.
• Scope
• The report provides a snapshot of the global
  clinical trials landscape
• Report provides top level data related to the
  clinical trials by Region, Country (G7 E7) ,
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• The report provides all the unaccomplished trials
  (Terminated, Suspended and Withdrawn) with reason
  for unaccomplishment
• The Report provides enrollment trends for the
  past five years
• Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/glycog
  en-storage-disorders-gsd-global-clinical-trials-re
  view-h2-2015-market

3


Table of Content
Table of Contents 2List of Tables 3List of
Figures 3Report Guidance 4Clinical Trials by
Region 5Clinical Trials and Average Enrollment
by Country 6Top Countries Contributing to
Clinical Trials in Asia-Pacific 8Top Five
Countries Contributing to Clinical Trials in
Europe 9Top Countries Contributing to Clinical
Trials in North America 10Top Countries
Contributing to Clinical Trials in Middle East
and Africa 11Clinical Trials by G7 Countries
Proportion of Glycogen Storage Disorders (GSD) to
Genetic Disorders Clinical Trials 12Clinical
Trials by Phase in G7 Countries 13Clinical
Trials in G7 Countries by Trial Status
14Clinical Trials by E7 Countries Proportion of
Glycogen Storage Disorders (GSD) to Genetic
Disorders Clinical Trials 15Clinical Trials by
Phase in E7 Countries 16Clinical Trials in E7
Countries by Trial Status 17Clinical Trials by
Phase 18
4


Table of Content
In Progress Trials by Phase 19Clinical Trials by
Trial Status 20Clinical Trials by End Point
Status 21Clinical Trials by Sponsor Type
22Prominent Sponsors 23Top Companies
Participating in Glycogen Storage Disorders (GSD)
Therapeutics Clinical Trials 24Prominent Drugs
25Clinical Trial Profile Snapshots 26Appendix
44Abbreviations 44Definitions 44Research
Methodology 45Secondary Research 45About
GlobalData 46Contact Us 46Disclaimer 46Source
47 Enquire At http//www.researchbeam.com/gly
cogen-storage-disorders-gsd-global-clinical-trials
-review-h2-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/glycogen-storage-disor
ders-gsd-global-clinical-trials-review-h2-2015-mar
ket
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com